152 related articles for article (PubMed ID: 32010875)
1. The Incretin Effect in Female Mice With Double Deletion of GLP-1 and GIP Receptors.
Ahrén B; Yamada Y; Seino Y
J Endocr Soc; 2020 Feb; 4(2):bvz036. PubMed ID: 32010875
[TBL] [Abstract][Full Text] [Related]
2. Incretin hormone receptors are required for normal beta cell development and function in female mice.
Omar B; Ahlkvist L; Yamada Y; Seino Y; Ahrén B
Peptides; 2016 May; 79():58-65. PubMed ID: 27020250
[TBL] [Abstract][Full Text] [Related]
3. Increased insulin clearance in mice with double deletion of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors.
Tura A; Bizzotto R; Yamada Y; Seino Y; Pacini G; Ahrén B
Am J Physiol Regul Integr Comp Physiol; 2018 May; 314(5):R639-R646. PubMed ID: 29351421
[TBL] [Abstract][Full Text] [Related]
4. Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors.
Hansotia T; Baggio LL; Delmeire D; Hinke SA; Yamada Y; Tsukiyama K; Seino Y; Holst JJ; Schuit F; Drucker DJ
Diabetes; 2004 May; 53(5):1326-35. PubMed ID: 15111503
[TBL] [Abstract][Full Text] [Related]
5. GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms.
Flock G; Holland D; Seino Y; Drucker DJ
Endocrinology; 2011 Feb; 152(2):374-83. PubMed ID: 21068156
[TBL] [Abstract][Full Text] [Related]
6. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
Hansotia T; Drucker DJ
Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
[TBL] [Abstract][Full Text] [Related]
7. Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice.
Flock G; Baggio LL; Longuet C; Drucker DJ
Diabetes; 2007 Dec; 56(12):3006-13. PubMed ID: 17717280
[TBL] [Abstract][Full Text] [Related]
8. The Insulin Response to Oral Glucose in GIP and GLP-1 Receptor Knockout Mice: Review of the Literature and Stepwise Glucose Dose Response Studies in Female Mice.
Ahrén B; Yamada Y; Seino Y
Front Endocrinol (Lausanne); 2021; 12():665537. PubMed ID: 34122340
[TBL] [Abstract][Full Text] [Related]
9. Glucagon and insulin secretion, insulin clearance, and fasting glucose in GIP receptor and GLP-1 receptor knockout mice.
Tura A; Pacini G; Yamada Y; Seino Y; Ahrén B
Am J Physiol Regul Integr Comp Physiol; 2019 Jan; 316(1):R27-R37. PubMed ID: 30462524
[TBL] [Abstract][Full Text] [Related]
10. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
[TBL] [Abstract][Full Text] [Related]
11. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
[TBL] [Abstract][Full Text] [Related]
12. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.
Elahi D; McAloon-Dyke M; Fukagawa NK; Meneilly GS; Sclater AL; Minaker KL; Habener JF; Andersen DK
Regul Pept; 1994 Apr; 51(1):63-74. PubMed ID: 8036284
[TBL] [Abstract][Full Text] [Related]
13. Islet adaptation in GIP receptor knockout mice.
Ahrén B; Yamada Y; Seino Y
Peptides; 2020 Mar; 125():170152. PubMed ID: 31522751
[TBL] [Abstract][Full Text] [Related]
14. Contribution of GIP and GLP-1 to the Insulin Response to Oral Administration of Glucose in Female Mice.
Ahrén B
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831127
[TBL] [Abstract][Full Text] [Related]
15. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
[TBL] [Abstract][Full Text] [Related]
16. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
Pacini G; Thomaseth K; Ahrén B
Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
[TBL] [Abstract][Full Text] [Related]
17. Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength.
Mieczkowska A; Mansur S; Bouvard B; Flatt PR; Thorens B; Irwin N; Chappard D; Mabilleau G
Osteoporos Int; 2015 Jan; 26(1):209-18. PubMed ID: 25127672
[TBL] [Abstract][Full Text] [Related]
18. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Regul Pept; 2003 Jul; 114(2-3):115-21. PubMed ID: 12832099
[TBL] [Abstract][Full Text] [Related]
19. Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure.
Hansotia T; Maida A; Flock G; Yamada Y; Tsukiyama K; Seino Y; Drucker DJ
J Clin Invest; 2007 Jan; 117(1):143-52. PubMed ID: 17187081
[TBL] [Abstract][Full Text] [Related]
20. Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.
Vaag AA; Holst JJ; Vølund A; Beck-Nielsen HB
Eur J Endocrinol; 1996 Oct; 135(4):425-32. PubMed ID: 8921824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]